VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares fell 10.5% on Tuesday. The company traded as low as C$0.09 and last traded at C$0.09. Approximately 101,225 shares changed hands during mid-day trading, a decline of 17% from the average session volume of 122,051 shares. The stock had previously closed at C$0.10.
VentriPoint Diagnostics Price Performance
The company has a market cap of C$16.39 million, a P/E ratio of -4.25 and a beta of -1.07. The company has a current ratio of 0.12, a quick ratio of 6.67 and a debt-to-equity ratio of -68.25. The company’s 50-day moving average price is C$0.09 and its two-hundred day moving average price is C$0.11.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
- Off-Price, High-Yield: Why Ross Stores Is Defying the Retail Slump
- Whirlpool’s Stock Collapse Raises a Bigger Question About Its Recovery Potential
- Analysts Turn Bullish on Meta Platforms Despite Post-Earnings Fall
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
